Intervention Protocol

You have free access to this content

Intensity-modulated versus conventional radiotherapy for breast cancer

  1. Samir A. Hanna1,*,
  2. Gustavo N Marta1,
  3. Rachel Riera2,
  4. Joao LF da Silva1,
  5. Heloisa de Andrade Carvalho1,3,
  6. Alfredo Carlos SD De Barros4

Editorial Group: Cochrane Breast Cancer Group

Published Online: 28 MAR 2013

DOI: 10.1002/14651858.CD010420


How to Cite

Hanna SA, Marta GN, Riera R, da Silva JLF, de Andrade Carvalho H, De Barros ACSD. Intensity-modulated versus conventional radiotherapy for breast cancer (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD010420. DOI: 10.1002/14651858.CD010420.

Author Information

  1. 1

    Hospital Sirio Libanes, Radiation Oncology Department, Sao Paulo, Brazil

  2. 2

    Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  3. 3

    Faculdade de Medicina, Universidade de Sao Paulo, Radiation Oncology Department, Sao Paulo, Brazil

  4. 4

    Hospital Sirio Libanes, Breast Cancer Department, Sao Paulo, Brazil

*Samir A. Hanna, Radiation Oncology Department, Hospital Sirio Libanes, Sao Paulo, Brazil. samir.hanna@hsl.org.br.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

References

Additional references

Al-Ghazal 1999
  • Al-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?. European Journal of Surgical Oncology 1999;25(6):571-3.
Barnett 2011
  • Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, et al. Randomized controlled trial of forward-planned intensity-modulated radiotherapy for early breast cancer: interim results at 2 years. International Journal of Radiation Oncology, Biology and Physics 2012;82(2):715-23.
Bartelink 2001
  • Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. New England Journal of Medicine 2001;345(19):1378-87.
Bernstein 2005
  • Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. Journal of the National Cancer Institute 2005;97(22):1671-9.
Berry 2005
  • Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. New England Journal of Medicine 2005;353(17):1784-92.
Degnim 2007
  • Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. Journal of Clinical Oncology 2007;25(19):2671-7.
Donovan 2007
  • Donovan E, Bleakley N, Denholm E, Evans P, Gothard L, Hanson J, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiotherapy and Oncology 2007;82(3):254-64.
EBCTCG 2005a
  • Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-717.
EBCTCG 2005b
  • Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366(9503):2087-106.
Fernando 1996
  • Fernando IN, Ford HT, Powles TJ, Ashley S, Glees JP, Torr M, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clinical Oncology (Royal College of Radiologists) 1996;8(4):226-33.
Fisher 2002
  • Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine 2002;347(16):1233-41.
Harris 1979
  • Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. International Journal of Radiation Oncology, Biology, Physics 1979;5(2):257-61.
Henderson 2010
  • Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Annals of Internal Medicine 2010;152(7):444-55.
Higgins 2011a
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
Hsieh 1990
  • Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. International Journal of Cancer 1990;46(5):796-800.
ICRU 62
Jatoi 2007
  • Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. Journal of Clinical Oncology 2007;25(13):1683-90.
Jemal 2010
Kelsey 1981
  • Kelsey JL, Fischer DB, Holford TR, LiVoisi VA, Mostow ED, Goldenberg IS, et al. Exogenous estrogens and other factors in the epidemiology of breast cancer. Journal of the National Cancer Institute 1981;67(2):327-33.
Lahmann 2004
Lichtenstein 2000
  • Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. New England Journal of Medicine 2000;343(2):78-85.
Lipworth 2009
McCormick 2011
NCCN 2011
  • Carlson RW, Allred DC, Anderson BO, Burnstein HJ, Edge SB, Farrar WB, et al. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (Breast Cancer). http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf Accessed 13 July 2011; Vol. Version 2, issue 1:5-9.
Parkin 2005
Parmar 1998
Peto 2000
Pignol 2008
  • Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. Journal of Clinical Oncology 2008;26(13):2085–92.
Ravdin 2007
  • Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. New England Journal of Medicine 2007;356(16):1670-4.
Recht 2001
  • Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology 2001;19(5):1539-69.
RevMan
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Roychoudhuri 2007
  • Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Møller H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer 2007;7:9.
Smith 2011
  • Smith BD, Pan IW, Shih YC, Smith GL, Harris JR, Punglia R, et al. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. Journal of the National Cancer Institute 2011;103(10):798-809.
Veronesi 2002
  • Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine 2002;347(16):1227-32.
Webb 2003